Delivery Order SPE2DB24D3013-SPE2DB25FFPRV
- Not listed
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,182.88 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Valsartan-HCZ 160-25 mg tablets in a quantity of 90 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,054.55 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 160-25 mg tablets (90-count) on August 19, 2025, with completion scheduled for August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's substantial pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,457.93 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 320-25 mg tablets in a 90-count quantity. This is a firm fixed price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,067.90 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-25 mg tablets (90-count packaging). The contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, utilizing firm fixed-price terms with no set-aside designation. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $3,084.13 delivery order to AmerisourceBergen Drug Corp for Valsartan-HCT 320-25 mg tablets (90-count units) with an ultimate completion date of June 3, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCT 160-25 mg tablets (90-count) valued at $2,284.16, with an ultimate completion date of September 2, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $5,582.42 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on August 19, 2025, with completion scheduled for August 20, 2025. This non-competitive delivery order utilizes firm fixed pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- The Defense Logistics Agency awarded a delivery order valued at $36,196.14 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procedures and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a $2,581.62 delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 80-12.5 mg tablets (90-count supply) on February 13, 2025, with completion scheduled for February 14, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFPRVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,768.94 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 160-25 mg tablets in quantities of 90 per unit. This competitively awarded, non-set-aside contract employs firm fixed price terms with an ultimate completion date of August 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling the contractor to supply brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. AmerisourceBergen's status as a major pharmaceutical distributor and its demonstrated capability to fulfill federal medical procurement requirements through open competition has established it as a critical vendor for Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/21/25 |